MEDENOX

Mentioned in	?		References in periodicals archive	?		Medical browser	?		Full browser	?
trial	Similarly to the initial demonstration of the benefit of thromboprophylaxis for acutely ill medical patients, first established by the MEDENOX trial, the EXCLAIM study should be a landmark trial in advancing the standard of care of patients at high risk for VTE and it further establishes enoxaparin as a reference treatment for VTE prophylaxis in acutely ill medical patients. New Study Demonstrated That Extending Prophylaxis With Lovenox(R) ... by PR Newswire The results of EXCLAIM will expand on the earlier MEDENOX (Prophylaxis in MEDical patients with ENOXaparin) study, which found that daily 40-mg subcutaneous injections of Lovenox for six to 14 days reduced the incidence of VTE in acutely ill medical patients during hospitalization by 63 percent compared with placebo, without increasing the risk of major hemorrhage. Multinational Study Will Examine the Safety and Efficacy of Prolonged ... by PR Newswire Professor of Medicine & Co-Principal Investigator of the MEDENOX Trial, McMaster University, Hamilton, Ontario, Canada B-Roll * Dr. FDA Approves Drug for the Prevention of Blood Clots In Acutely Ill ... by PR Newswire	meclofenamate meclofenamate sodium meclofenamic acid Meclomen mecocephaly meconism meconium meconium aspiration meconium aspiration syndrome meconium ileus meconium periorchitis meconium peritonitis meconium plug syndrome meconium-stained amniotic fluid Mectizan MED Med Tech Med.Sc.D meda MEDAC syndrome Medawar medcard Medea Medea Complex medehas MEDENOX medetomidine medevac Medex medi- media Media Epidemic Media Malpractice medial medial antebrachial cutaneous nerve medial arteriosclerosis medial brachial cutaneous nerve medial calcaneal nerve medial calcific sclerosis medial cerebellar nucleus medial circumflex femoral artery Medial collateral ligament injury medial cord of brachial plexus medial crest medial cuneiform bone medial cutaneous nerve of arm medial cutaneous nerve of calf medial cutaneous nerve of forearm medial fibroplasia medial forebrain bundle medial geniculate body	Medeia Amiranashvili Medeia Figner Medeia Ivanovna Figner Medeia Petrovna Amiranashvili Medeival period Medeival period Medel Medellin Medellin Medellín Medellín Medellín (Colombia) Medellín (Colombia) Medellin cartel Medellín cartel Medellín, Antioquia Medellín, Antioquia Medellin, Colombia Medellin, Colombia Medellín, Colombia Medellín, Colombia Medellin, Colombia - Enrique Olaya Herrara Medellin, Colombia - La Playas Medem, Nikolai Medem, Nikolai Vasilevich MedEmerg International, Inc. Medenilla Medenilla Medenitsa MEDENOX Medeo Medeola virginiana MEDEP mederi Medes Medes Medes Medeski Scofield Martin & Wood Medeski, Martin, and Wood medetomidine Medetomidine-Zolazepam-Tiletamine medevac medevac medevac medevac medevaced medevaced medevacing medevacing medevacked medevacked medevacking medevacking medevacs medevacs MEDEVAL Medew MEDEX MEDEX MEDEX

Mentioned in

References in periodicals archive

Medical browser

Full browser

Similarly to the initial demonstration of the benefit of thromboprophylaxis for acutely ill medical patients, first established by the MEDENOX trial, the EXCLAIM study should be a landmark trial in advancing the standard of care of patients at high risk for VTE and it further establishes enoxaparin as a reference treatment for VTE prophylaxis in acutely ill medical patients.

New Study Demonstrated That Extending Prophylaxis With Lovenox(R) ... by PR Newswire

The results of EXCLAIM will expand on the earlier MEDENOX (Prophylaxis in MEDical patients with ENOXaparin) study, which found that daily 40-mg subcutaneous injections of Lovenox for six to 14 days reduced the incidence of VTE in acutely ill medical patients during hospitalization by 63 percent compared with placebo, without increasing the risk of major hemorrhage.